| David Moatazedi | President and Chief Executive Officer | FY2025 | |
| Tatjana Mitchell | Chief Financial Officer | FY2025 | |
| Sandra Beaver | Former Chief Financial Officer | FY2025 | |
| Rui Avelar, M.D. | Chief Medical Officer and Head of Research and Development | FY2025 | |
| Tomoko Yamagishi-Dressler | Former Chief Marketing Officer | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.